Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA or Inhaled UFH in COVID-19
NCT04466670Phase 2Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin, heparin in coronavirus disease 2019 (COVID-19), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Status: unknown.
02
Drugs
aspirinheparin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04466670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04466670.